Northwestern University
Clinical trials sponsored by Northwestern University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a website make your doctor visit faster and clearer? Results expected Sep 2026 (estimated)
- Botox shot into bladder during prostate surgery may ease urgent bathroom trips Results expected Sep 2026 (estimated)
- Necklace camera watches what you eat, no audio needed Results expected Sep 2026 (estimated)
- Air cuffs boost walking in blocked leg arteries? Results expected Sep 2026 (estimated)
- Kidney Drug's hidden heart benefits under the microscope Results expected Sep 2026 (estimated)
-
Could a cholesterol drug help restore sudden hearing loss?
Disease control Stopped earlyThis trial asks whether adding an oral statin to the usual steroid treatment can improve recovery from sudden sensorineural hearing loss, a condition where hearing drops rapidly in one ear. Adults diagnosed within 30 days of symptom onset will receive either a statin or a placebo…
Phase 4 • Sponsor: Northwestern University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a malaria drug help fight resistant colon cancer?
Disease control Stopped earlyThis study tests whether adding hydroxychloroquine (a drug used for malaria) to standard targeted therapy can help shrink tumors in people with advanced colorectal cancer that has a specific BRAF mutation and has stopped responding to prior treatments. The trial enrolled 7 adults…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Experimental AML drug trial halted early after only 8 patients
Disease control Stopped earlyThis early-stage trial tested a new drug called tomivosertib in 8 adults with acute myeloid leukemia (AML) that had come back or not responded to prior treatments. The goal was to find a safe dose and check for side effects. The study was stopped early, so results are limited.
Phase 1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Promising combo for IDH1 leukemia hits early snag – trial stopped
Disease control Stopped earlyThis early-phase trial tested whether adding the targeted drug ivosidenib to standard FLAG chemotherapy could help people with a specific genetic form of acute myeloid leukemia (IDH1-mutant AML). The study aimed to find the best dose and check for side effects in patients whose c…
Phase 1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart surgery shock drug trial stalls after just two patients
Disease control Stopped earlyThis study tested angiotensin II (Giapreza) as a first-line treatment for distributive shock in patients who had a heart transplant or LVAD implant. The goal was to see if it could reduce the need for other blood pressure medications. However, the trial was terminated early after…
Phase 4 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Heart risk check for schizophrenia drugs
Disease control Stopped earlyThis study aimed to see how two antipsychotic drugs, aripiprazole and ziprasidone, affect heart risk in people with schizophrenia, schizoaffective disorder, or bipolar disorder. Researchers measured blood fats and heart electrical changes in 48 adults over 12 months. The trial wa…
Phase 3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Pain relief study halted: did d-cycloserine fail for back pain?
Symptom relief Stopped earlyThis study tested whether D-cycloserine, a drug that affects brain signaling, could reduce pain in people with chronic low back pain that had not responded to other treatments. About 200 adults with at least 6 months of back pain and an average pain score of 4 or higher (on a 0–1…
Phase 2 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can less pressure mean better fibroid surgery?
Symptom relief Stopped earlyThis study looked at whether using a lower fluid pressure (60 mmHg) during hysteroscopy, a procedure to remove fibroids, works as well as the standard pressure (80 mmHg). The goal was to see if it improves surgery time, fluid use, and surgeon's view. The study was stopped early a…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Can a stomach stent predict who gets better? small study tests new approach for gastroparesis
Knowledge-focused Stopped earlyThis study tested whether placing a temporary metal stent in the stomach outlet could predict if a patient with severe gastroparesis would later benefit from a permanent procedure called GPOEM. Only 8 adults with gastroparesis that didn't improve with standard treatments took par…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a smartphone app prevent kidney stones from coming back?
Knowledge-focused Stopped earlyThis study looked at whether using a mobile health platform, alone or with regular doctor visits, helps kidney stone patients follow treatment guidelines and improve their quality of life. Researchers planned to enroll 75 adults who have had kidney stones. The study was terminate…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC